Cardinal Health Inc vs Charter Communications Inc — how do they compare? Cardinal Health Inc trades at $234.16 (market cap $55.88B), while Charter Communications Inc trades at $150.25 (market cap $18.81B). The key difference: Cardinal Health Inc is far larger — about 3× Charter Communications Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while Charter Communications Inc pays none. Which is the better fit depends on your goals.
| CAH | CHTR | |
|---|---|---|
Market Cap | $55.88B | $18.81B |
Sector | Health | Media |
52-Week High | $240.26 | $282.74 |
52-Week Low | $146.04 | $123.31 |
Enterprise Value | $59.91B | $115.01B |
Dividend Yield | 0.86% | — |
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $235.3, down 0.79% on the day, but remains near its 52-week high. The stock exhibits a bullish technical signal with consistent earnings beats in recent quarters, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue for fiscal 2025 was $222.58 billion, with net income reaching $1.56 billion. Analyst consensus is strongly positive, with 18 buys and a $266.43 price target, reflecting confidence in the company's pharmaceutical and specialty business growth.
The outlook for CAH is favorable, driven by robust earnings performance and optimistic fiscal 2027 guidance. Key opportunities include sustained demand for specialty drugs and operational efficiency gains. Risks involve high debt levels, with a debt-to-asset ratio of 16.09 in 2025, and competitive pressures in the healthcare distribution sector. Investors should weigh strong analyst support against balance sheet leverage and market volatility.
Charter Communications (CHTR) trades at $150.25, down 1.99% amid volatile broadband sector pressures. The stock shows mixed technical signals with bullish moving averages but overbought RSI readings. Fundamentally, CHTR maintains strong profitability with 9.05% net margins and attractive valuation at 4.1 P/E, though facing revenue declines and subscriber losses. Recent debt refinancing activities and aggressive buybacks highlight management's focus on capital structure optimization.
Investment outlook remains cautious despite deep value metrics. The 10.6% upside to consensus $166.18 target offers potential, but persistent broadband competition and high debt load ($93.2B) create headwinds. Mobile growth and network investments provide long-term catalysts, yet near-term subscriber trends warrant monitoring for sustained recovery.
Trailing returns across standard periods
Latest headlines on both assets
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 54 million U.S. homes and businesses, around 40% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest U.S. cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
Read more on CHTR →